Ling‐Yi Kong

11.6k citations

375 papers · 9.8k indexed · h-index 50

Pharmacology top 0.1%
- Cholinesterase and Neurodegenerative Diseases 25
- Ginger and Zingiberaceae research 22
Complementary and alternative medicine top 0.1%
Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 25
- Ginger and Zingiberaceae research 22
Toxicology top 0.5%
Biochemistry top 1%
- Traditional and Medicinal Uses of Annonaceae 23
Molecular Biology
- Natural product bioactivities and synthesis 106
- Phytochemical compounds biological activities 33
Plant Science
- Phytochemistry and Biological Activities 43
Analytical Chemistry
- Chromatography in Natural Products 38
Biomaterials
- Phytochemistry and Bioactive Compounds 25

Co-authors: Jian‐Guang Luo Xiaobing Wang Junsong Wang Jun Luo Chao Zhang Ming‐Hua YangLei YangXuefeng Huang
Cited by: Pharmacology Complementary and alternative medicine
Journals: European Journal of Medicinal Chemistry (23 papers)Chinese Journal of Natural Medicines (19 papers)Journal of Natural Products (15 papers)
Partner nations: China Japan United Kingdom

In The Last Decade

Ling‐Yi Kong

370 papers receiving 9.6k citations

Peers

Countries citing papers authored by Ling‐Yi Kong

Since Specialization

Citations

This map shows the geographic impact of Ling‐Yi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Yi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Yi Kong more than expected).

Fields of papers citing papers by Ling‐Yi Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Yi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Yi Kong. The network helps show where Ling‐Yi Kong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ling‐Yi Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling‐Yi Kong Line = papers co-authored together Ling‐Yi Kong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of dual CDK4/6 and BRD4 inhibitor as apoptosis and autophagy inducers against NSCLC in vitro and in vivo European Journal of Medicinal Chemistry ·Yonglei Zhang,Zhongwen Luo,Yuhan Jiang,Long Tai Zheng,Liangliang Ma,Yiwei Zheng,Min Zou,Ling‐Yi Kong,Xiaobing Wang	2025	2
2	Limonoid walrobsin A alleviates LPS-induced septic acute kidney injury through modulating inflammatory microenvironment by targeting G protein-coupled receptor 75 Phytomedicine ·Pengfei Tang,Houli Jiang,D. S. Hwang,Seito Nonoda,Ling‐Yi Kong,Jun Luo	2025	0
3	A novel liver-targeted and highly selective fluorescent probe for hepatic hydrogen sulfide detection in the diagnosis of drug-induced liver injury European Journal of Medicinal Chemistry ·Yalin Li,Bing Liao,Qunyou Tan,C. Ott,Ling‐Qiang Zhu,Nehad El-barky,Chen Chen,Feiyan Liu,Ling‐Yi Kong,Jian‐Guang Luo	2025	5
4	Impact of digital transformation on green and sustainable innovation in business: a quasi-natural experiment based on smart city pilot policies in China Environment Development and Sustainability ·Ling‐Yi Kong,Tahmasebi Cryus	2024	4
5	Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease European Journal of Medicinal Chemistry ·Zhongwen Luo,Shang Li,Yonglei Zhang,Fucheng Yin,Heng Luo,Xinye Chen,Aganov Vv,Siyuan Wan,Xinxin Li,Ling‐Yi Kong,Xiaobing Wang	2023	9
6	Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer European Journal of Medicinal Chemistry ·C. Ott,Chen Chen,Min Kong,Ling Zhu,Yalin Li,Jianfei Zhang,英二中垣,R. Dalley,Ling‐Yi Kong,Jian‐Guang Luo	2023	12
7	Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice Pharmacological Research ·D.A. Konovalova,Catherine Gvozden,Wen Tang,刘英军,ليث عبدالحسين فرحان العتابي,Jinhu Chen,HE Gui-qin,Zhang Feng-h,Jun Luo,Ling‐Yi Kong,Chao Zhang	2022	28
8	Shizukaol A exerts anti-inflammatory effect by regulating HMGB1/Nrf2/HO-1 pathway Phytomedicine ·Pengfei Tang,純也西野,Shanting Liao,Shanshan Wei,Farahmand Meghdad,Wen‐Jun Xu,Dong‐Rong Zhu,Jun Luo,Ling‐Yi Kong	2021	32
9	Functional characterization of cinnamate 4-hydroxylase from Helianthus annuus Linn using a fusion protein method Gene ·Ziwen Wang,Stefan Böhmer,Yucheng Zhao,Shan Li,Zhonghuan Yang,Li Li,Ling‐Yi Kong,Jun Luo	2020	10
10	Metabolomic Assessment of Acute Cholestatic Injuries Induced by Thioacetamide and by Bile Duct Ligation, and the Protective Effects of Huang-Lian-Jie-Du-Decoction Frontiers in Pharmacology ·Dandan Wei,Junsong Wang,Jin‐Ao Duan,Ling‐Yi Kong	2018	20
11	Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway Scientific Reports ·Ting Ma,Bo‐Yi Fan,Chao Zhang,Huijun Zhao,Chao Han,Caiyun Gao,Jian‐Guang Luo,Ling‐Yi Kong	2016	24
12	The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-κB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells Inflammation ·Ruijun Li,Caiyun Gao,Chao Guo,Miaomiao Zhou,Jun Luo,Ling‐Yi Kong	2016	45
13	A bird's eye view of anisatin induced convulsive seizures in brain by a 1H NMR based metabolic approach Molecular BioSystems ·Dandan Wei,علاء الدين سعد متولي,เกษตร น้อยทิพย์,Junsong Wang,Minghui Li,Ming‐Hua Yang,Ling‐Yi Kong	2014	6
14	NMR-based metabolomics approach to study the chronic toxicity of crude ricin from castor bean kernels on rats Molecular BioSystems ·เกษตร น้อยทิพย์,Junsong Wang,L Martel Rivera,Dandan Wei,Minghui Li,Ming‐Hua Yang,Ling‐Yi Kong	2014	22
15	Toxicity assessment of Arisaematis Rhizoma in rats by a 1H NMR-based metabolomics approach Molecular BioSystems ·L Martel Rivera,Junsong Wang,เกษตร น้อยทิพย์,Dandan Wei,Ming‐Hua Yang,Ling‐Yi Kong	2014	24
16	Flavonostilbenes from Sophora alopecuroides L. as multidrug resistance associated protein 1 (MRP1) inhibitors Natural Product Research ·Kai Ni,Lei Yang,Chuanxing Wan,Yuan‐Zheng Xia,Ling‐Yi Kong	2014	21
17	Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells Food and Chemical Toxicology ·Yadi Geng,Lei Yang,Chao Zhang,Ling‐Yi Kong	2014	36
18	aH nuclear magnetic resonance-based metabolomics reveals sex-specific metabolic changes of gastrodin intervention in rats Asian Pacific Journal of Tropical Medicine ·N. L. Ascher,Yuanwei Jia,Junsong Wang,Ming‐Hua Yang,Kelvin D.G. Wang,Ling‐Yi Kong	2014	3
19	Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease Bioorganic & Medicinal Chemistry Letters ·Renshi Li,Xiaobing Wang,Xiaojun Hu,Ling‐Yi Kong	2013	83
20	Two New Triterpenoid Saponins from the Roots ofGypsophila paniculata with Potent α-Glucosidase Inhibition Activity Chinese Journal of Natural Medicines ·Shun Yao,Jian‐Guang Luo,Li Ma,Ling‐Yi Kong	2011	5

About Ling‐Yi Kong

Ling‐Yi Kong is a scholar working on Pharmacology, Toxicology and Complementary and alternative medicine, having authored 375 papers that have together received 9.8k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (106 papers), Phytochemistry and Biological Activities (43 papers), Chromatography in Natural Products (38 papers), Phytochemical compounds biological activities (33 papers), Phytochemistry and Bioactive Compounds (25 papers), Cholinesterase and Neurodegenerative Diseases (25 papers), Traditional and Medicinal Uses of Annonaceae (23 papers) and Ginger and Zingiberaceae research (22 papers). The work is most often cited by research in Pharmacology (1.4k citations), Complementary and alternative medicine (1.1k citations) and Pharmacology (1.9k citations). Ling‐Yi Kong has collaborated with scholars based in China, Japan and United Kingdom. Frequent co-authors include Jian‐Guang Luo, Xiaobing Wang, Junsong Wang, Jun Luo, Chao Zhang, Ming‐Hua Yang, Lei Yang, Xuefeng Huang, Yuan‐Zheng Xia and Jianguang Luo. Their work appears in journals such as European Journal of Medicinal Chemistry, Chinese Journal of Natural Medicines, Journal of Natural Products, Fitoterapia and Journal of Chromatography A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact